Cargando…

Stability of trivalent human papillomavirus (types 16, 18, 58) recombinant vaccine (Escherichia coli)

Detalles Bibliográficos
Autores principales:	Liu, Yu-Ying, Zhang, Hai-Jiang, Shen, Er-Cui, Chen, Dan, Wang, Yan, Fu, Si-Jia, Yin, Fei, Zhang, Gui-Feng, Shen, Yi-Guo, Liu, Yong-Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710327/ https://www.ncbi.nlm.nih.gov/pubmed/34282064 http://dx.doi.org/10.1097/CM9.0000000000001659

Ejemplares similares

Cross-neutralizing antibody titres against non-vaccine types induced by a recombinant trivalent HPV vaccine (16/18/58) in rhesus macaques
por: Wang, Yan, et al.
Publicado: (2020)

Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine
por: Wan, Bing, et al.
Publicado: (2022)

A novel trivalent HPV 16/18/58 vaccine with anti-HPV 16 and 18 neutralizing antibody responses comparable to those induced by the Gardasil quadrivalent vaccine in rhesus macaque model
por: Yin, Fei, et al.
Publicado: (2017)

Potential transferability of mcr-3 via IS26-mediated homologous recombination in Escherichia coli
por: Wang, Zheng, et al.
Publicado: (2018)

Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study
por: Zhang, Donghong, et al.
Publicado: (2010)

Differential expression of human papillomavirus 16-, 18-, 52-, and 58-derived transcripts in cervical intraepithelial neoplasia
por: Baba, Satoshi, et al.
Publicado: (2020)

Ancient Evolutionary History of Human Papillomavirus Type 16, 18 and 58 Variants Prevalent Exclusively in Japan
por: Tanaka, Kohsei, et al.
Publicado: (2022)

Antibodies to Human Papillomavirus 16, 18, 58, and 6b Major Capsid Proteins among Japanese Females
por: Matsumoto, Koji, et al.
Publicado: (1997)

Extragenital Human Papillomavirus 16-associated Bowen's Disease
por: Montesu, Maria Antonietta, et al.
Publicado: (2017)

Prognostic evaluation of human papillomavirus and p16 in esophageal squamous cell carcinoma
por: Zhang, Cheng-Juan, et al.
Publicado: (2020)

Whole-Genome Analysis of Human Papillomavirus Types 16, 18, and 58 Isolated from Cervical Precancer and Cancer Samples in Chinese Women
por: Liu, Ying, et al.
Publicado: (2017)

Genetic variability, phylogeny and functional implication of the long control region in human papillomavirus type 16, 18 and 58 in Chengdu, China
por: Fang, Liyuan, et al.
Publicado: (2020)

Safety and immunogenicity of an Escherichia coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trial
por: Chu, Kai, et al.
Publicado: (2023)

Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58
por: de Sanjosé, Silvia, et al.
Publicado: (2019)

Safety of human papillomavirus 6, 11, 16 and 18 (recombinant): systematic review and meta-analysis
por: Coelho, Pedro Luiz Spinelli, et al.
Publicado: (2015)

Expression and Purification of Recombinant Hemoglobin in Escherichia coli
por: Natarajan, Chandrasekhar, et al.
Publicado: (2011)

Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand
por: Khunamornpong, Surapan, et al.
Publicado: (2016)

Gardner fibroma with localized hypertrichosis without adenomatous polyposis coli gene mutation
por: Yao, Xue-Yan, et al.
Publicado: (2019)

Distribution of Human Papillomavirus 52 and 58 Genotypes, and Their Expression of p16 and p53 in Cervical Neoplasia
por: Kim, Tae Eun, et al.
Publicado: (2014)

Update on the Keio collection of Escherichia coli single-gene deletion mutants
por: Yamamoto, Natsuko, et al.
Publicado: (2009)

Serogroup distribution, antibiogram patterns & prevalence of ESBL production in Escherichia coli
por: Thakur, R., et al.
Publicado: (2016)

Replication and transcription of human papillomavirus type 58 genome in Saccharomyces cerevisiae
por: Li, Jing, et al.
Publicado: (2010)

Draft Genome Sequences of the Enteroinvasive Escherichia coli Strains M4163 and 4608-58
por: Leonard, Susan R., et al.
Publicado: (2015)

A role for ColV plasmids in the evolution of pathogenic Escherichia coli ST58
por: Reid, Cameron J., et al.
Publicado: (2022)

The effects of low levels of trivalent ions on a standard strain of Escherichia coli (ATCC 11775) in aqueous solutions
por: Deng, Can, et al.
Publicado: (2018)

Analysis of Escherichia coli O157 clinical isolates by multilocus sequence typing
por: Rajkhowa, Swaraj, et al.
Publicado: (2010)

Ancient Evolution and Dispersion of Human Papillomavirus 58 Variants
por: Chen, Zigui, et al.
Publicado: (2017)

Human Papillomavirus Type 7 Messenger RNA was found in Two Cases with Warts in Toe Webs
por: Sun, Caihong, et al.
Publicado: (2017)

Human Papillomavirus Genotyping in Cutaneous Warts of Koreans by Sequencing
por: Kim, Kang Su, et al.
Publicado: (2021)

Human papillomavirus 16L1-58L2 chimeric virus-like particles elicit durable neutralizing antibody responses against a broad-spectrum of human papillomavirus types
por: Chen, Xue, et al.
Publicado: (2017)

Preparation of umami octopeptide with recombined Escherichia coli: Feasibility and challenges
por: Zhao, Liming, et al.
Publicado: (2017)

Presence of the narrow-spectrum OXA-1 β-lactamase enzyme is associated with elevated piperacillin/tazobactam MIC values among ESBL-producing Escherichia coli clinical isolates (CANWARD, 2007–18)
por: Walkty, A., et al.
Publicado: (2022)

Integration of human papillomavirus 16 in esophageal carcinoma samples
por: Li, Shuying, et al.
Publicado: (2017)

Carbapenem resistance in a rural part of southern India: Escherichia coli versus Klebsiella spp.
por: Sekar, Ramalingam, et al.
Publicado: (2016)

Prevention of cervical, vaginal, and vulval cancers: role of the quadrivalent human papillomavirus (6, 11, 16, 18) recombinant vaccine
por: Diaz, Maria Lina
Publicado: (2010)

Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines
por: Mariz, Filipe Colaço, et al.
Publicado: (2020)

Seroprevalence of Human Papillomavirus Types 6, 11, 16 and 18 in Chinese Women
por: Ji, Jia, et al.
Publicado: (2012)

Characteristics of human papillomavirus infection among females and the genetic variations of HPV18 and HPV58 in Henan province, China
por: Wang, Ying, et al.
Publicado: (2023)

Effective inhibition of lytic development of bacteriophages λ, P1 and T4 by starvation of their host, Escherichia coli
por: Łoś, Marcin, et al.
Publicado: (2007)

CT041 CAR T cell therapy for Claudin18.2-positive metastatic pancreatic cancer
por: Qi, Changsong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nolvecekpv0gce9s30p0a6uhc5